What a reporter found when uncovering why federal agents allowed a deadly drug to hit the streets

AP

What a reporter found when uncovering why federal agents allowed a deadly drug to hit the streets

JIM MUSTIAN
Updated
5 min read

This photo provided by the U.S. Drug Enforcement Administration shows pills containing fentanyl which were seized by the DEA in New Mexico, on April 28, 2025. (DEA via AP)

(DEA via AP)

ALBUQUERQUE, N.M. (AP) — Jim Mustian reported and co-wrote an Associated Press story that revealed the U.S. Drug Enforcement Administration permitted hundreds of thousands of fentanyl pills to be distributed in New Mexico as part of an effort to build bigger federal prosecutions.

Mustian, along with AP journalist Joshua Goodman, reviewed hundreds of internal DEA records and interviewed current and former agents, including a whistleblower who claims his agency gambled with public safety and violated U.S. Justice Department rules about seizing the dangerous synthetic opioid. The White House last year designated fentanyl as a “ weapon of mass destruction.”

This is an interview of Mustian by Del Quentin Wilber, who edited the story.

It is usually very hard to get such an inside account of DEA operations. Where did the idea come from and how did you track it down?

Goodman, my AP colleague, first spotted the whistleblower complaint accusing the DEA of allowing fentanyl to hit the streets of New Mexico. The report was sent to the White House in September but escaped media attention at the time.

Advertisement

As government records often go, it was heavily redacted to shield not only the whistleblower’s identity but the amount of fentanyl that was not seized.

There was a critical oversight in the government’s redactions. I noticed that the whistleblower’s name ended in an “l” — a single letter that, for some reason, was missed by the black marker.

I sent a flurry of messages on LinkedIn to DEA agents whose named ended in “l” and had worked in Albuquerque. One afternoon in March, I was at my desk when I received a response from an agent who connected me to the whistleblower, David Howell. A couple weeks later I flew to New Mexico and met with Howell.

The DEA has long allowed drugs to ‘walk,’ as you described it in the story, in an effort to catch bigger dealers. What is different about fentanyl that makes this tactic, in the eyes of some current and former agents, problematic?

The simple answer: the sheer potency and lethality of fentanyl. In its “One Pill Can Kill” campaign, the DEA warns that just a couple of milligrams — an amount that would fit on the tip of a pencil — is enough to kill the average adult. Nowadays with fentanyl, we’re usually talking about counterfeit pills designed to mimic name-brand painkillers. The pills are almost always manufactured by cartels in Mexican labs and contain an unknown amount of fentanyl.

Advertisement

Our reporting highlighted the example of a 2023 fentanyl shipment that DEA agents monitored — but did not seize — at an Albuquerque mobile home park. Agents gathered such detailed intelligence that they wrote in their investigative report that 74,000 pills had been delivered. Howell told me that decision, which came as fatal overdoses hit their peak around the country, was akin to “providing one fentanyl pill to each person at a football stadium.”

Federal officials defended the decision to not seize the drugs.